Erythropoietic Protoporphyria (EPP)
8 clinical trials · Condition
◉ Watch Erythropoietic Protoporphyria (EPP)
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria (NCT03520036) | Tanabe Pharma America, Inc. | 2018-07-05 |
| Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC)) (NCT01880983) | University of Alabama at Birmingham | 2011-11-01 |
| Expanded Access Program of Bitopertin For Participants With EPP or XLP (NCT07603401) | Disc Medicine, Inc |
Track Erythropoietic Protoporphyria (EPP) automatically
Every clearance here is in the API, with alerts when new ones post.